Overview

A Study for Patients With Head and Neck Cancer

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This study will compare the effects of pemetrexed plus cisplatin versus cisplatin alone in head and neck cancer patients.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Cisplatin
Pemetrexed